P698 Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn’s disease and ulcerative colitis patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.